secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kronos Bio, Inc. (—)
CIK:        0001741830
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001140361-24-011945
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Kronos Bio cuts workforce by 21%, extends cash runway into H2 2026
------------------------------------------------------------------

- Board approved ~21% workforce reduction; completion expected March 7, 2024.
- Expects ~$0.5M in cash severance charges in Q1 2024, and up to ~$0.1M for COBRA.
- Existing cash resources expected to support operations into second half of 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1741830/000114036124011945/0001140361-24-011945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1741830/000114036124011945/ef20023567_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-011945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer